Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Asset Utilization Ratio (2023 - 2025)

Iovance Biotherapeutics has reported Asset Utilization Ratio over the past 4 years, most recently at 0.29 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.29 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 0.29 (changed N/A YoY), and the annual figure for FY2025 was 0.29, up 48.91%.
  • Asset Utilization Ratio for Q4 2025 was 0.29 at Iovance Biotherapeutics, up from 0.28 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for IOVA hit a ceiling of 0.29 in Q4 2025 and a floor of 0.0 in Q2 2023.
  • Median Asset Utilization Ratio over the past 3 years was 0.11 (2024), compared with a mean of 0.13.
  • Peak annual rise in Asset Utilization Ratio hit 9719.44% in 2025, while the deepest fall reached 9719.44% in 2025.
  • Iovance Biotherapeutics' Asset Utilization Ratio stood at 0.0 in 2023, then soared by 58.43% to 0.0 in 2024, then surged by 12461.07% to 0.29 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.29 (Q4 2025), 0.28 (Q3 2025), and 0.26 (Q2 2025) per Business Quant data.